Protagonist Therapeutics
PTGX
#3524
Rank
NZ$4.87 B
Marketcap
$79.48
Share price
-3.83%
Change (1 day)
70.30%
Change (1 year)

P/S ratio for Protagonist Therapeutics (PTGX)

P/S ratio as of April 2025 (TTM): 6.57

According to Protagonist Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.23. At the end of 2024 the company had a P/S ratio of 5.34.

P/S ratio history for Protagonist Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.34-75.75%
202322.09.16%
202220.2-66.16%
202159.796.96%
202030.3-96.35%
201983116361.66%
20185.05-76.83%
201721.8
2016N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA